← Back to Home

Ovaries Continue to Remodel After Menopause: Protein Study Reveals Aging Changes Beyond the Reproductive Years

Ovarian tissue from 28 women shows that inflammation and tissue structure continue to change with age after reproductive function ends. Some molecular signals overlap with ovarian cancer research, but key evidence is still needed before these findings can inform cancer prediction or prevention measures.

By SURL BioNews

Menopause marks a turning point in reproductive life, but it may not mark the end of biological activity in the ovaries. Women often live for decades after menopause, yet detailed human data on how the ovaries change during this time have been lacking. A new study examining protein composition found that the ovaries continue to remodel with age after reproductive function ends.

According to an announcement from Northwestern University in the United States, the study by a team from Northwestern University and the Buck Institute for Research on Aging was published on October 14 in *Aging Cell*. The researchers analyzed normal ovarian tissue from 28 postmenopausal women aged 50 to 75, using mass spectrometry to measure 5,812 protein groups and examine molecular differences across postmenopausal age groups, rather than simply comparing young and old ovaries.

Proteomic analysis is like taking a molecular snapshot of tissue: the relative abundance of different proteins can offer clues about cellular activity and tissue condition. The team examined the data using several statistical methods, all of which showed that the ovaries did not remain in a fixed state. Differences were particularly pronounced between women in their 50s and those aged 70 and older.

Younger postmenopausal ovaries retained more proteins involved in maintaining cell and tissue structure, while older tissue showed more signals of inflammation, immune activity, and the breakdown and rebuilding of the scaffolding surrounding cells. These changes also overlapped with some molecular features of cellular senescence—even after cells stop dividing, they may still influence their surroundings by releasing signals.

Another finding brought the question into cancer research: none of the samples had cancer, but certain proteins that have drawn attention in ovarian cancer research were also more abundant in aging ovaries. This suggests that normal aging and cancer may involve some shared biological processes. It does not establish that the tissue has become cancerous, is in a precancerous state, or will necessarily develop cancer in the future.

The study remains limited in scope. Comparing tissue from 28 people is not the same as following the aging process in the same group of women over decades, and the study did not prove that these protein changes cause disease. Whether continued ovarian remodeling helps maintain tissue, reflects normal aging, or may increase certain health risks still requires larger studies and functional research to clarify.

A more concrete research direction at present is to identify which molecules can reliably distinguish normal aging from disease, then test whether they are suitable as biomarkers or starting points for prevention research. These findings have not yet established a usable cancer screening tool, nor are they sufficient to support removing healthy ovaries after menopause. Their first implication for researchers is that understanding women's health in later life requires viewing the ovaries as more than reproductive organs whose work is complete.

References

  1. Northwestern University